9th HBV Cure Workshop supported by ANRS | Emerging Infectious Diseases

9th HBV Cure Workshop supported by ANRS | Emerging Infectious Diseases

by
528 528 people viewed this event.

The 9th HBV Cure Workshop, organized by ANRS | EID, will take place on Tuesday, July 5, 2022. This year, the meeting will be organized in Lyon, France in a hybrid way.

Program

9:30 am – 9:45 am Welcome 

Yazdan Yazdanpanah (Director of ANRS) & Fabien Zoulim (ANRS HBV cure Task Force)

9:45 am – 11:15 am Session I: Clinical trials

Chairs: Hélène Fontaine & Jean-Michel Pawlotsky  
  •  Clinical development of direct acting antivirals for chronic hepatitis B – MF Yuen (Hong Kong) 
  • Clinical development of immune therapies for chronic hepatitis BHarry Janssen (Rotterdam, the Netherlands) 
  • Emerging therapies for chronic hepatitis DeltaMarc Bourlière (Marseille, France) 

Roundtable discussion: what will be the best combination strategies ? 

11:15 am – 11:30 am Coffee Break 

11:30 am – 1:00 pm Session II: Immune responses

Chairs: David Durantel & Hélène Strick-Marchand  
  •  New advances in the immunobiology of HBV infectionMatteo Iannacone (Milan, Italy) 
  • Novel therapeutic vaccines in development – Robert Thimme (Freiburg, Germany) Digital 
  • Mechanisms of HBV-HDV interference – Julie Lucifora (Lyon, France) 

Roundtable discussion  

 1:00 pm – 2:00 pm Lunch Break 

2:00 pm – 3:30 pm Session III: Virology 

Chairs: Michael Kann & Patrick Soussan 
  •  cccDNA formation and DNA repair processesAlexander Ploss (Princeton, USA) 
  • Crosstalk between HBV and the 3D GenomeChristine Neuveut (Montpellier, France) 
  • Targeting HBV cccDNA persistence by gene editing approachesBarbara Testoni (Lyon, France) 

Roundtable discussion 

3:30 pm – 3:45 pm Tea & Coffee Break

 

 

3:45 pm – 5:35 pm Session IV: Assessing the liver reservoir 

Chairs: Massimo Levrero & Vincent Leroy  
  •  cccDNA quantification for the investigation of new therapiesLena Allweiss (Hamburg, Germany) 
  • HBV integration and new HBV-associated drivers of hepatocarcinogenesisJean-Charles Nault (Paris, France) 
  • Assessment of the intrahepatic immune responses Adam Gehring (Toronto, Canada) 
  • Non invasive biomarkers to monitor the cccDNA reservoirSofia Perez del Pulgar (Barcelona, Spain) 

 Roundtable discussion : fine needle aspirates or peripheral biomarkers ?

 

5.35 pm – 6.00 pm Session V: Roundtable discussion 

Chairs: Harry Janssen & Sofia Perez del Pulgar 
  •  What are the remaining key challenges to cure HBV and HDV ? (contributors TBD)

6:00 pm Farewell – Fabien Zoulim

 

6.00 pm – 7.00 pm Get together cocktail 

 

To register for this event please visit the following URL: http://Forthcoming →

 

Date And Time

July 5, 2022
May 19, 2022
 

Location

Online Event
 

Event Types

Share With Friends

Recently Published Protocols